Lipoprotein(a) in subjects with familial defective apolipoprotein B100
- 作者Y.F.Nicholas Perombelon; John J. Gallagher; Nicholas B. Myant; Anne K. Soutar; Brian L. Knight
- 卷第92卷
- 文件大小1021.26KB
- 发表时间1992
- DOI10.1016/0021-9150(92)90279-p
- 页码203-212
Neopterin levels in patients with coronary artery disease are independent of chlamydia pneumoniae seropositivityDavid A Smith; Emmanouil G Zouridakis; Matteo Mariani; Salim Fredericks; Della Cole; Juan Carlos Kaski · 2003
Prognostic value of neopterin levels in treated patients with hypertension and chest pain but without obstructive coronary artery diseasePablo Avanzas; Ramón Arroyo-Espliguero; Juan Cosin-Sales; Juan Quiles; Emmanouil Zouridakis; Juan Carlos Kaski · 2004
Evaluation of serum neopterin levels in patients with chronic coronary artery disease and hyperlipidaemia before and after lipid lowering treatmentKiriakou, P.; Papadopoulos, T.; Salame, M.; Dhar, S.; Steele, H.; Ecob, R.; Haq, I.; Oakley, D. · Atherosclerosis Supplements · 2001
ASSOCIATION OF CIRCULATING LEVELS OF NEOPTERIN WITH PLAQUE VULNERABILITY IN PATIENTS WITH CORONARY ARTERY DISEASE AN ANGIOGRAM, OPTICAL COHERENT TOMOGRAPHY AND INTRAVASCULAR ULTRASOUND STUDYHe, Jieqiong; Tian, Jinwei; Yu, Bo · Journal of the American College of Cardiology · 2015
Skin autofluorescence is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advanced glycation end productsDouwe J. Mulder; Paul L. van Haelst; Sascha Gross; Karina de Leeuw; Johan Bijzet; Reindert Graaff; Rijk O. Gans; Felix Zijlstra; Andries J. Smit · 2008